Details

Autor(en) / Beteiligte

• Tong, Ling
• Li, Wenping
• Lo, Michael Man-Chu
• Gao, Xiaolei
• Wai, Jenny Miu-Chen
• Rudd, Michael
• Tellers, David
• Joshi, Aniket
• Zeng, Zhizhen
• Miller, Patricia
• Salinas, Cristian
• Riffel, Kerry
• Haley, Hyking
• Purcell, Mona
• Holahan, Marie
• Gantert, Liza
• Schubert, Jeffrey W
• Jones, Kristen
• Mulhearn, James
• Egbertson, Melissa
• Meng, Zhaoyang
• Hanney, Barbara
• Gomez, Robert
• Harrison, Scott T
• McQuade, Paul
• Bueters, Tjerk
• Uslaner, Jason
• Morrow, John
• Thomson, Fiona
• Kong, Jongrock
• Liao, Jing
• Selyutin, Oleg
• Bao, Jianming
• Hastings, Nicholas B
• Agrawal, Sony
• Magliaro, Brian C
• Monsma, Frederick J
• Smith, Michelle D
• Risso, Stefania
• Hesk, David
• Hostetler, Eric
• Mazzola, Robert

Titel

Discovery of [11C]MK-6884: A Positron Emission Tomography (PET) Imaging Agent for the Study of M4Muscarinic Receptor Positive Allosteric Modulators (PAMs) in Neurodegenerative Diseases

Ist Teil von

• Journal of medicinal chemistry, 2020-03, Vol.63 (5), p.2411-2425

Ort / Verlag

United States: American Chemical Society

Erscheinungsjahr

2020

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• The measurement of receptor occupancy (RO) using positron emission tomography (PET) has been instrumental in guiding discovery and development of CNS directed therapeutics. We and others have investigated muscarinic acetylcholine receptor 4 (M4) positive allosteric modulators (PAMs) for the treatment of symptoms associated with neuropsychiatric disorders. In this article, we describe the synthesis, in vitro, and in vivo characterization of a series of central pyridine-related M4 PAMs that can be conveniently radiolabeled with carbon-11 as PET tracers for the in vivo imaging of an allosteric binding site of the M4 receptor. We first demonstrated its feasibility by mapping the receptor distribution in mouse brain and confirming that a lead molecule 1 binds selectively to the receptor only in the presence of the orthosteric agonist carbachol. Through a competitive binding affinity assay and a number of physiochemical properties filters, several related compounds were identified as candidates for in vivo evaluation. These candidates were then radiolabeled with 11C and studied in vivo in rhesus monkeys. This research eventually led to the discovery of the clinical radiotracer candidate [11C]­MK-6884.